Ligand validation:5BNY

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5BNY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5BNY_NAG_A_403	33%	77%	0.2	0.879	0.18	0.73	-	1	0	0	100%	0.9333
5BNY_NAG_C_402	7%	40%	0.262	0.716	1.15	1.25	1	1	0	0	100%	0.9333
5BNY_NAG_E_404	6%	70%	0.367	0.809	0.62	0.5	1	-	0	0	100%	0.9333
5BNY_NAG_A_402	6%	64%	0.339	0.78	0.29	1.05	-	1	0	0	100%	0.9333
5BNY_NAG_A_401	5%	82%	0.341	0.76	0.39	0.41	-	-	0	0	100%	0.9333
5BNY_NAG_C_403	5%	81%	0.444	0.846	0.3	0.51	-	-	0	0	100%	0.9333
5BNY_NAG_C_401	4%	89%	0.34	0.703	0.29	0.36	-	-	0	0	100%	0.9333
5BNY_NAG_E_401	0%	46%	0.598	0.54	0.7	1.38	1	2	0	0	100%	0.9333
5BQY_NAG_C_402	20%	50%	0.244	0.85	0.82	1.12	1	1	0	0	100%	0.9333
5BQZ_NAG_C_401	9%	66%	0.3	0.794	0.4	0.87	-	1	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.